1049026-36-9

Basic information

• Product Name: 3-Bromo-5-chloro-benzenesulfonyl chloride
• Synonyms: 3-Bromo-5-chloro-benzenesulfonyl chloride;3-bromo-5-chlorophenylsulfonyl chloride
• CAS NO: 1049026-36-9
• Molecular Formula: C6H3BrCl2O2S
• Molecular Weight: 289.97
• Mol File: 1049026-36-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Bromo-5-chloro-benzenesulfonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-5-chloro-benzenesulfonyl chloride(1049026-36-9)
• EPA Substance Registry System: 3-Bromo-5-chloro-benzenesulfonyl chloride(1049026-36-9)

Safety Data

• Hazardous Substances Data: 1049026-36-9(Hazardous Substances Data)

Usage

General Description

3-bromo-5-chloro-benzenesulfonyl chloride is a chemical compound with the molecular formula C6H3BrClO2S and a molecular weight of 259.51 g/mol. It is a sulfonyl chloride derivative with both bromine and chlorine substitution on the benzene ring. 3-bromo-5-chloro-benzenesulfonyl chloride is often used as a reagent in organic synthesis, particularly in the development of pharmaceutical compounds and agrochemicals. It is known for its high reactivity and ability to form covalent bonds with a wide range of nucleophiles, making it a valuable tool in the production of various chemical intermediates. Due to its potential for hazardous reactions, 3-bromo-5-chloro-benzenesulfonyl chloride should be handled with caution and stored in a controlled environment.

Upstream product

• 96558-78-0 3-bromo-5-chlorophenylamine 

Downstream Products

• 1198614-85-5 3-bromo-5-chloro-N-methylbenzenesulfonamide 
• 1263376-19-7 3-bromo-5-chlorobenzenethiol 

Relevant articles and documents

ACLY INHIBITORS AND USES THEREOF

The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.

SULFONAMIDE COMPOUNDS AND THE USE

The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

NEW ARYLSULPHONYLGLYCINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS

The invention relates to substituted arylsulphonylglycine derivatives of general formula (I) wherein the groups Ra to Rf, A and Z are defined as in the specification and claims, which are suitable for preparing a pharmaceutical composition for the treatment of metabolic disorders, particularly type 1 or type 2 diabetes mellitus.